Navigation Links
Elbow Cryo/Cuff™

ProductsElbow Cryo/Cuff™
Company Aircast
Item Elbow Cryo/Cuff™
Features 
  • Anatomic cuff design for complete coverage of affected area
  • Measured compression for patient comfort
  • Controlled cold eliminates the risk of tissue damage
  • Detachable cooler allows for uninterrupted treatment
  • Sizes for both adult and pediatric patients
  • Indication: epicondylitis (tennis elbow), throwing injury, and post-op
  • Description The Elbow Cryo/Cuff combines the therapeutic benefits of controlled compression to minimize hemarthrosis and swelling, and cold to minimize pain. The cuff is anatomically designed to completely fit the elbow providing maximum cryotherapy. The Elbow Cryo/Cuff is available in an adult size in addition to a pediatric size. All Cryo/Cuffs can be ordered as a single cuff, or with a cooler (including a tube assembly and insulation disk). The Cooler is available separately and can be used with any model in the Cryo/Cuff line.
    Info Aircast
    Customer Service: (800) 526-8785
    Web site: http://www.aircast.com/

    Related medicine products :

    1. Elbow Fixator
    2. DJD II Dynamic Elbow Joint Distractor
    3. AliMed® Bendable Elbow Orthosis
    4. ACTION™ Elbow Wrap
    5. QualCare™ ROM Elbow Orthosis
    6. AliMed® Turnbuckle Elbow Orthosis
    7. Mayo Clinic Elbow Brace
    8. Comfy™ Dynamic Elbow Torque Orthosis
    9. Comfy™ Elbow and Hand Spasticity Orthosis
    10. Zeuba Vital Elbow Support
    11. XR Cubital Tunnel Elbow Splint
    The ECG-9110 meets IEC60601-2-51 new international standard for digital electrocardiographs specifying accuracy and digital filter performance. It is the world's smallest and lightest 12 channel inte
    Cruise Control is a device developed by STAAR as a filter between the phaco handpiece and aspiration tubing that captures nuclear material, enhances the safety and efficiency of phaco procedures by e
    ...consists of six analyzer models providing a range ...tests include pH, PCO 2 , PO 2 , SO 2 %, hematocri... chloride, glucose, and lactate. Test results are ...g design provides the smallest footprint of any an...
    ...an VISION ensures flexibility in system configurat...leepscan VISION utilizes the powerful Netlink ampl...gh a standard Ethernet connection. Only computer i...llowing the Sleepscan VISION to take advantage of ...
    Medicine Products:
    (Date:7/9/2008)...day OnBase deployment critical in electronic healt...atients, CLEVELAND, July 9 /PRNewswire/ -- Hyland...ocument management software suite, announced that ...since the deployment of,OnBase in March. Based in ...states, SSM is a forward-thinking health care prov...
    (Date:7/9/2008)... March 8 - 11, 2009, CLEVELAND, Jul...e,innovative ideas and experiences, the Managed Ca...nnual forum for CIOs and senior health-plan leader...oming MCEG forum, which has earned a reputation fo...nities, will be at the Sheraton Wild,Horse Pass Re...
    (Date:7/9/2008)... This first-of-its-kind Diamond Elite ...ot to graze, chip or develop cracks. , ... After two years in development, The Kitchen Bath ...eased the newest design in walk-in tubs: Diamond ... low 1-inch-high entry and is 3-times thicker and ...
    (Date:7/9/2008)... The Detail Bag II is an integrated sal...s and other sales professionals who carry samples.... than the first Detail Bag (DB-XL). This thin, l...pired by direct customer feedback. The DB2 is con...ith a steel frame for durability and functionality...
    Breaking Medicine News(10 mins):Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 2Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 3Health News:Affordability Crisis in Managed Care Explored at Conference of Health Plan Executives 2Health News:The Kitchen Bath Store Releases Newest Design in Walk-In Tubs 2Health News:The Kitchen Bath Store Releases Newest Design in Walk-In Tubs 3Health News:Texas Detailed Products Today Announced the Second Generation Detail Bag: Skinceuticals Chooses the Detail Bag II Sample Case for all its Pharmaceutical Representatives 2Health News:Texas Detailed Products Today Announced the Second Generation Detail Bag: Skinceuticals Chooses the Detail Bag II Sample Case for all its Pharmaceutical Representatives 3
    ...ndia by the George Institute for International Hea...dia were at a higher risk of developing lifestyle .... In a developing area of Andhra Pradesh, about 1...re found to have diabetes and another 16 per cent ...
    ...ekhawat Tuesday launched the Youth Unite For Victo...ness on HIV/AIDS// among the 450 million youths of...try of youth affairs, will be carried out by the N...O) in collaboration with other organisations, incl...
    ...ce the risks associated with erectile dysfunction ... the Harvard School of Public Health (HSPH) reveal...with obesity and smoking habit whereas a negative ...al activity and healthy lifestyle. A prospective ...
    ...transplant surgeries, doctors are rethinking on th...n Health Ethics Committee (AHEC) is deliberating /...conducted on patients who are brain-dead and on th...organs before it deteriorates. The guidelines unde...
    Other Medicine News:Health News:Alarming Rise of Diabetes in Rural India - Survey Reports 2Health News:Vice President Launches AIDS Awareness Campaign for Youth 2Health News:Erectile Dysfunction Linked with Smoking and Obesity – Study Report 2
    (Date:7/9/2008)...-- Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ) to...ending,dose Phase 1b clinical trial of APD791 to e...d pharmacodynamics. APD791 is Arena,s internally,d...atment of arterial,thrombosis and other related co...ouble-blind, placebo-controlled,multiple-ascendin...
    (Date:7/8/2008)...wswire/ -- A great deal of,scientific evidence sho...statins can help prevent coronary artery disease. ...well documented, as many as 40 percent of,patients...rug for less than,one year. Doctors believe that s... poor understanding of statin benefits and patient...
    (Date:7/8/2008)...dpoints in ENGAGE Trial, KENILWORTH, N.J., July 8...(NYSE: SGP ) announced today that corifollitropin...ant (SFS) met its primary endpoints,in the Phase I...g a,Schering-Plough-sponsored symposium at the 24t...Reproduction and Embryology (ESHRE) in Barcelona,...
    (Date:7/7/2008)...ANA598 and ANA773 Acting via Independent ... Conference Call Today at 2:00 PM PDT, SAN...armaceuticals,Inc. (Nasdaq: ANDS ) announced tod...he Toll-Like Receptor-7 (TLR7) mechanism for the,t...cal pharmacology testing,and the results of comple...
    Breaking Medicine Technology:Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 2Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 4Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 5Fish Oil and Red Yeast Rice Studied for Lowering Blood Cholesterol 2Fish Oil and Red Yeast Rice Studied for Lowering Blood Cholesterol 3Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 2Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5Mergers and New Facilities Abound in Washington D C Suburbs 12857 1Mergers and New Facilities Abound in Washington D C Suburbs 12857 2American Oriental Bioengineering to Report Fourth Quarter and Full Year 2007 Financial Results 12855 1American Oriental Bioengineering to Report Fourth Quarter and Full Year 2007 Financial Results 12855 2Abbott Genentech and WEHI Collaborate to Research and Develop New Anti Cancer Drugs 12853 1Abbott Genentech and WEHI Collaborate to Research and Develop New Anti Cancer Drugs 12853 2A Once Daily Oral Drug for Chronic Obstructive Pulmonary Disease That Treats COPD Related Inflammation Could Achieve Blockbuster Status 12851 1A Once Daily Oral Drug for Chronic Obstructive Pulmonary Disease That Treats COPD Related Inflammation Could Achieve Blockbuster Status 12851 2